Does RASBURICASE Cause Rash maculo-papular? 10 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Rash maculo-papular have been filed in association with RASBURICASE (Elitek). This represents 1.1% of all adverse event reports for RASBURICASE.
10
Reports of Rash maculo-papular with RASBURICASE
1.1%
of all RASBURICASE reports
0
Deaths
4
Hospitalizations
How Dangerous Is Rash maculo-papular From RASBURICASE?
Of the 10 reports, 4 (40.0%) required hospitalization.
Is Rash maculo-papular Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RASBURICASE. However, 10 reports have been filed with the FAERS database.
What Other Side Effects Does RASBURICASE Cause?
Tumour lysis syndrome (116)
Methaemoglobinaemia (92)
Off label use (90)
Product use in unapproved indication (76)
Bacterial infection (75)
Fungal infection (73)
Cellulitis (72)
Clostridium difficile colitis (72)
Lymphoid tissue hypoplasia (72)
Lymphopenia (72)
What Other Drugs Cause Rash maculo-papular?
SULFAMETHOXAZOLE\TRIMETHOPRIM (935)
AMOXICILLIN (871)
VANCOMYCIN (642)
PIPERACILLIN\TAZOBACTAM (629)
PANTOPRAZOLE (589)
LAMOTRIGINE (568)
ALLOPURINOL (550)
CARBOPLATIN (529)
ACETAMINOPHEN (499)
CLINDAMYCIN (484)
Which RASBURICASE Alternatives Have Lower Rash maculo-papular Risk?
RASBURICASE vs RAVULIZUMAB
RASBURICASE vs RAVULIZUMAB-CWVZ
RASBURICASE vs REBAMIPIDE
RASBURICASE vs REBETOL
RASBURICASE vs REBIF